LGM Pharma Expands Manufacturing in Texas and Colorado

LGM Pharma announced an additional $9 million investment in manufacturing operations across Rosenberg, Texas, and Colorado Springs, Colorado. The March 19 announcement brings total investment in the expansion program to $15 million. The Rosenberg facility is adding suppository and semi-solid manufacturing capacity, while the Colorado Springs site is expanding oral solid dose production. Company officials said the projects will increase contract development and manufacturing capabilities while maintaining ongoing operations. Chief Commercial Officer Hamilton Lenox said the expansion supports growing customer demand across multiple pharmaceutical product categories.